phrykt

Sensus Healthcare, Inc. (SRTS): who owns it and who trades it

As of Nov 16, 2026, SRTS insiders reported 13 purchases worth $708K in the last 12 months. The largest buyer was Eric Sachetta (Director), with $543K. 2 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Sensus Healthcare

From the latest filings

Overall: more buying than selling. Insiders mostly bought. Funds and famous investors were close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns SRTS

38 funds and institutions reported SRTS shares worth $11M at the end of Q2 2026, about 22% of the company. The largest holder is Pacific Ridge Capital Partners, LLC with 4.8%.

Funds and institutions (13F) 22%Everyone else 78%

10 largest owners, by share of the company

Pacific Ridge Capital Partners, LLC4.8%
Vanguard Capital Management LLC4.0%
Dimensional Fund Advisors LP1.9%
Divisadero Street Capital Management, LP1.7%
Renaissance Technologies LLC1.5%
Geode Capital Management, LLC0.9%
UBS Group AG0.9%
Sachetta, LLC0.9%
Greenline Wealth Management LLC0.8%
North Star Investment Management Corp.0.8%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
Pacific Ridge Capital Partners, LLC789,6754.80%$2.4M-1%
Vanguard Capital Management LLC660,4024.01%$2M+2%
Dimensional Fund Advisors LP316,1211.92%$955K-18%
Divisadero Street Capital Management, LP278,4851.69%$841K-3%
Renaissance Technologies LLC242,3341.47%$732K-4%
Geode Capital Management, LLC154,1520.94%$466K-7%
UBS Group AG152,5730.93%$461K-12%
Sachetta, LLC152,0080.92%$459K+1%
Greenline Wealth Management LLC128,7740.78%$389KNo change
North Star Investment Management Corp.125,5860.76%$379KNo change
Bank of New York Mellon Corp100,4100.61%$303KNo change
BlackRock, Inc.83,5550.51%$252K+17%
Vanguard Fiduciary Trust Co76,2890.46%$230K+1%
State Street Corp69,2520.42%$209KNo change
Ingalls & Snyder LLC55,0000.33%$166KNo change
Mindset Wealth Management, LLC52,1000.32%$157KNo change
Janney Montgomery Scott LLC40,5760.25%$123KNo change
Northern Trust Corp28,1870.17%$85.1K-59%
Chapin Davis, Inc.26,0000.16%$78.5KNo change
American Century Companies Inc21,2720.13%$64.2KNo change

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, SRTS insiders reported $708K of open-market purchases and $0 of sales.

Purchases, 12 months
$708K
13 trades, 3 people
Sales, 12 months
$0
0 trades, 0 people
Sales under a 10b5-1 plan
–
Share of sale value
Latest trade
Aug 31, 2026
Filed Aug 31, 2026

Purchases and sales by month

$563K$563KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Aug 31, 2026Eric SachettaDirectorPurchase27,304$3.54$96.7KForm 4
Aug 28, 2026Eric SachettaDirectorPurchase37,537$3.44$129KForm 4
Aug 27, 2026Eric SachettaDirectorPurchase10,925$3.18$34.7KForm 4
Aug 26, 2026Eric SachettaDirectorPurchase9,708$3.29$31.9KForm 4
Aug 24, 2026Eric SachettaDirectorPurchase34,697$3.25$113KForm 4
Aug 21, 2026Eric SachettaDirectorPurchase7,000$3.25$22.8KForm 4
Aug 20, 2026Joseph C SardanoCEOPurchase20,000$3.02$60.4KForm 4
Aug 20, 2026Eric SachettaDirectorPurchase24,000$3.13$75.1KForm 4
May 12, 2026Eric SachettaDirectorPurchase1,500$3.34$5KForm 4
Feb 24, 2026Eric SachettaDirectorPurchase2,000$3.81$7.6KForm 4
Nov 21, 2025Eric SachettaDirectorPurchase7,000$3.93$27.5KForm 4
Nov 18, 2025Joseph C SardanoCEOPurchase25,000$4.03$101KForm 4
Nov 18, 2025Michael SardanoPresidentPurchase1,000$3.80$3.8KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Eric SachettaDirector$543K–Aug 31, 2026
Joseph C SardanoCHIEF EXECUTIVE OFFICER, Director$161K–Aug 20, 2026
Michael SardanoPRESIDENT AND GENERAL COUNSEL, Director$3.8K–Nov 18, 2025
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

SRTS short interest

Low short interest. 1.4% of SRTS shares are sold short: about 1 share in 74. Over the last 12 reports the number of shares short went up 9%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 222,266 SRTS shares were sold short, 1.4% of the shares outstanding, down 3.3% from the report before. At the average daily volume of 30,908 shares, buying them all back would take about 7.2 trading days (days to cover).

Shares short, % of all shares

1.35%May 15Oct 301.43%

Days to cover

7.2May 15Oct 3016.3

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 2026222,2661.35%-3%30,9087.2
Oct 15, 2026229,9061.40%+1%16,02814.3
Sep 30, 2026227,5821.38%+0%29,0177.8
Sep 15, 2026227,2091.38%+5%26,1878.7
Aug 31, 2026216,1751.31%+3%57,3453.8
Aug 14, 2026209,1801.27%+2%23,7198.8
Jul 31, 2026205,8721.25%+2%20,24110.2
Jul 15, 2026202,0541.23%+1%23,7918.5
Jun 30, 2026200,8211.22%+4%45,0104.5
Jun 15, 2026193,0471.17%-4%69,6402.8
May 29, 2026200,0921.22%-2%48,8714.1
May 15, 2026204,1611.24%-34%128,2091.6

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Sensus Healthcare company events

Sensus Healthcare filed 7 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership, auditor). The latest was on Aug 13, 2026.

  1. Aug 13, 2026ResultsReleased financial results. Filing
  2. Jun 5, 2026AgreementSensus Healthcare, Inc. entered into a Loan Agreement with City National Bank of Florida pursuant to which CNB has made available to the Company a revolving credit facility providing for maximum borrowings of $15 million, which is evidenced by a Revolving Promissory Note, dated June 2, 2026, made… Filing
  3. Jun 2, 2026VoteReported shareholder vote results. Filing
  4. May 7, 2026ResultsReleased financial results. Filing
  5. Feb 12, 2026ResultsReleased financial results. Filing
  6. Jan 20, 2026AuditorChanges in Registrant’s Certifying Accountant Sensus Healthcare, Inc. was notified that Carr, Riggs & Ingram, LLC acquired, effective as of January 1, 2026, certain assets related to the capital markets practice of Berkowitz Pollack Brant Advisors + CPAs, LLP. Filing
  7. Jan 12, 2026LeadershipThe Board of Directors of Sensus Healthcare, Inc. appointed Larry Biscotti as a Class I director of the Company for a term expiring at the Company’s annual meeting in 2028. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Sensus Healthcare financials

Famous investors that hold SRTS

2 of the 50 well-known investors we track reported holding SRTS in their latest 13F filing. The largest position is Jim Simons's, worth $687K.

FundQuarterSharesValueOf portfolioChange
Jim Simons · Renaissance TechnologiesQ3 2026229,634$687K0.0%-5%
Ken Griffin · Citadel AdvisorsQ3 202630,391$90.9K0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Sensus Healthcare, Inc. (SRTS) stock

Who owns the most SRTS stock?

The largest reported owner of Sensus Healthcare, Inc. (SRTS) is Pacific Ridge Capital Partners, LLC, with 4.8% of the company. In total, 38 funds and institutions reported holding SRTS at the end of Q2 2026, together about 22% of the shares. See the largest owners.

Are SRTS insiders buying or selling?

In the last 12 months, SRTS insiders reported 13 open-market purchases worth $708K and no sales. The latest trade was on Aug 31, 2026. See every trade.

What is the short interest in SRTS?

As of Oct 30, 2026, 222,266 SRTS shares were sold short, 1.4% of the shares outstanding, down 3.3% from the report before. At the average daily volume of 30,908 shares, buying them all back would take about 7.2 trading days (days to cover). See the history.

Which famous investors hold SRTS?

2 of the 50 well-known investors we track reported SRTS in their latest 13F filing, including Jim Simons, Ken Griffin. The largest position is worth $687K. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.